authors
- Cao, Chuanhai
- Arendash, Gary W
- David M. Holtzman, MD
- David M. Holtzman, MD
- Potter, Huntington
- Cirrito, John R
- Lin, Xiaoyang
- Wang, Li
- Verges, Deborah K
- Dickson, Alexander
- Dickson, Alexander
- Mamcarz, Malgorzata
- Mori, Takashi
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2009
published in
has subject area
- Age Factors
- Alzheimer Disease
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
- Analysis of Variance
- Animals
- Brain
- Caffeine
- Central Nervous System Stimulants
- Cognition
- Cytokines
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Humans
- Maze Learning
- Mice
- Mice, Transgenic
- Microdialysis
- Phosphodiesterase Inhibitors
- Plasma
- Presenilin-1
- Theophylline
- Time Factors